Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells

Introduction: Developing potent therapeutic vaccines against human papillomaviruses (HPVs) is crucial for the effective management of various HPV-associated cancers. DNA-based vaccines are attractive due to their safety, stability, and capacity to elicit a targeted immune response against specif...

Full description

Saved in:
Bibliographic Details
Main Authors: Reyhane Najafi1, Azam Bolhassani2*, Maryam Montazeri1, Elnaz Agi3
Format: Article
Language:English
Published: Pasteur Institute of Iran 2023-09-01
Series:Journal of Medical Microbiology and Infectious Diseases
Subjects:
Online Access:https://jommid.pasteur.ac.ir/article-1-586-en.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850277944982765568
author Reyhane Najafi1
Azam Bolhassani2*
Maryam Montazeri1
Elnaz Agi3
author_facet Reyhane Najafi1
Azam Bolhassani2*
Maryam Montazeri1
Elnaz Agi3
author_sort Reyhane Najafi1
collection DOAJ
description Introduction: Developing potent therapeutic vaccines against human papillomaviruses (HPVs) is crucial for the effective management of various HPV-associated cancers. DNA-based vaccines are attractive due to their safety, stability, and capacity to elicit a targeted immune response against specific antigens. Heat shock proteins (HSPs) can enhance the efficacy of DNA vaccines when used as adjuvants. In this study, we created a recombinant DNA molecule by fusing the HPV16 e7 gene with either the hspB1 or hsp27 gene and assessed its expression in a eukaryotic cell line. Methods: Initially, we constructed a recombinant eukaryotic expression vector by inserting the hsp27-e7 fusion gene into the pcDNA3.1 (-) vector. The concentration and purity of the sample were evaluated using NanoDrop spectrophotometry. We cultured human embryonic kidney 293T (HEK- 293T) cells in RPMI 1640 medium and transfected them with the pcDNA3.1-hsp27-e7 construct using Lipofectamine 2000 transfection reagent. After 48 hours, we assessed the expression of the Hsp27-E7 fusion protein by western blotting using an anti-E7 monoclonal antibody. Results: We successfully subcloned the hsp27-e7 fusion gene into the pcDNA3.1 (-) vector, and enzymatic digestion confirmed a distinct ~975 bp band on an agarose gel. The concentration and purity of the recombinant DNA vector in a 10 mL culture were measured to be 210 ng/μL and 1.86, respectively. Furthermore, the expression of the Hsp27-E7 fusion protein in HEK-293T cells was confirmed by Western blot analysis, which detected a distinct band of approximately 38 kDa. Conclusion: Our in vitro findings demonstrate successful expression of the DNA construct encoding the hsp27-e7 gene, which can be utilized as a DNA vaccine for future in vivo investigations.
format Article
id doaj-art-99fd3e51d08c4296be6bc40bcdcb187e
institution OA Journals
issn 2345-5349
2345-5330
language English
publishDate 2023-09-01
publisher Pasteur Institute of Iran
record_format Article
series Journal of Medical Microbiology and Infectious Diseases
spelling doaj-art-99fd3e51d08c4296be6bc40bcdcb187e2025-08-20T01:49:41ZengPasteur Institute of IranJournal of Medical Microbiology and Infectious Diseases2345-53492345-53302023-09-0111312313710.61186/JoMMID.11.3.123Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic CellsReyhane Najafi10https://orcid.org/0009-0009-2964-6386Azam Bolhassani2*1https://orcid.org/0000-0001-7363-7406Maryam Montazeri12https://orcid.org/0000-0003-2732-8551Elnaz Agi33https://orcid.org/0000-0003-3587-29521Department of Biotechnology, Faculty of Advanced Science and Technology, Islamic Azad University, Tehran Medical Branch, Tehran, Iran2Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran1Department of Biotechnology, Faculty of Advanced Science and Technology, Islamic Azad University, Tehran Medical Branch, Tehran, Iran3Iranian Comprehensive Hemophilia Care Center, Tehran, IranIntroduction: Developing potent therapeutic vaccines against human papillomaviruses (HPVs) is crucial for the effective management of various HPV-associated cancers. DNA-based vaccines are attractive due to their safety, stability, and capacity to elicit a targeted immune response against specific antigens. Heat shock proteins (HSPs) can enhance the efficacy of DNA vaccines when used as adjuvants. In this study, we created a recombinant DNA molecule by fusing the HPV16 e7 gene with either the hspB1 or hsp27 gene and assessed its expression in a eukaryotic cell line. Methods: Initially, we constructed a recombinant eukaryotic expression vector by inserting the hsp27-e7 fusion gene into the pcDNA3.1 (-) vector. The concentration and purity of the sample were evaluated using NanoDrop spectrophotometry. We cultured human embryonic kidney 293T (HEK- 293T) cells in RPMI 1640 medium and transfected them with the pcDNA3.1-hsp27-e7 construct using Lipofectamine 2000 transfection reagent. After 48 hours, we assessed the expression of the Hsp27-E7 fusion protein by western blotting using an anti-E7 monoclonal antibody. Results: We successfully subcloned the hsp27-e7 fusion gene into the pcDNA3.1 (-) vector, and enzymatic digestion confirmed a distinct ~975 bp band on an agarose gel. The concentration and purity of the recombinant DNA vector in a 10 mL culture were measured to be 210 ng/μL and 1.86, respectively. Furthermore, the expression of the Hsp27-E7 fusion protein in HEK-293T cells was confirmed by Western blot analysis, which detected a distinct band of approximately 38 kDa. Conclusion: Our in vitro findings demonstrate successful expression of the DNA construct encoding the hsp27-e7 gene, which can be utilized as a DNA vaccine for future in vivo investigations.https://jommid.pasteur.ac.ir/article-1-586-en.htmlhuman papillomavirus (hpv)e7small heat shock proteindna-based vaccinerecombinant dna constructeukaryotic cells
spellingShingle Reyhane Najafi1
Azam Bolhassani2*
Maryam Montazeri1
Elnaz Agi3
Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells
Journal of Medical Microbiology and Infectious Diseases
human papillomavirus (hpv)
e7
small heat shock protein
dna-based vaccine
recombinant dna construct
eukaryotic cells
title Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells
title_full Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells
title_fullStr Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells
title_full_unstemmed Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells
title_short Successful Expression of DNA-Based Vaccine Construct Encoding Human Papillomavirus Type 16 E7 Fused to Heat Shock Protein B1 in Eukaryotic Cells
title_sort successful expression of dna based vaccine construct encoding human papillomavirus type 16 e7 fused to heat shock protein b1 in eukaryotic cells
topic human papillomavirus (hpv)
e7
small heat shock protein
dna-based vaccine
recombinant dna construct
eukaryotic cells
url https://jommid.pasteur.ac.ir/article-1-586-en.html
work_keys_str_mv AT reyhanenajafi1 successfulexpressionofdnabasedvaccineconstructencodinghumanpapillomavirustype16e7fusedtoheatshockproteinb1ineukaryoticcells
AT azambolhassani2 successfulexpressionofdnabasedvaccineconstructencodinghumanpapillomavirustype16e7fusedtoheatshockproteinb1ineukaryoticcells
AT maryammontazeri1 successfulexpressionofdnabasedvaccineconstructencodinghumanpapillomavirustype16e7fusedtoheatshockproteinb1ineukaryoticcells
AT elnazagi3 successfulexpressionofdnabasedvaccineconstructencodinghumanpapillomavirustype16e7fusedtoheatshockproteinb1ineukaryoticcells